Legal Framework for Longevity and Health Businesses: Innovation and Risk

18.6.2026 | ARROWS law firm

Law for the longevity and health business fundamentally affects the pace of innovation, the safety of scaling, and the regulatory risks faced by clinics, digital platforms, or dietary supplement sales. This text outlines the key legal constraints and ways to set up a stable business model so that regulation is not a barrier, but a predictable framework for sustainable growth.

The photograph shows a specialist discussing the legal regulation of the longevity business.

Key takeaways
What longevity and the health business actually mean from a legal perspective
Protection of personal and genetic data and medical documentation
Liability for personal injury and product liability
Regulated changes in ownership structure and approval processes
International elements and cross-border provision of services

Key takeaways

In the longevity and health business environment, healthcare law, personal data protection, advertising regulation and investment law intersect. For entrepreneurs, it is therefore essential not to address individual legal issues in isolation, but to view the project as a regulated ecosystem.

A fundamental difference in the risk profile is created by the basic classification of what you offer. An incorrect choice of category between a healthcare service, wellness, a food supplement or a medical device leads in practice to high fines and distribution bans.

Digitalisation and artificial intelligence do open up new opportunities, but they also bring strict regulation of sensitive data protection and the application of the European AI Act. Without robust legal set-up, companies face major regulatory and reputational incidents.

The attorneys at ARROWS, a Prague-based law firm, have long operated at the intersection of healthcare regulation, technology and data law. If you need to set up your project safely or are already dealing with a dispute with a regulator, you can contact ARROWS at any time by email at office@arws.cz.

What longevity and the health business actually mean from a legal perspective

The term longevity and health business is used in practice for a wide range of activities, from traditional healthcare facilities through biohacking to digital applications. From a legal perspective, however, it is not a single category, but a complex mosaic of different legal regimes.

A basic mistake made by many entrepreneurs is trying to view the project only through the lens of one regime, for example solely as an e-shop selling food supplements. In operation, however, they often unknowingly also provide healthcare services or use software that shows the characteristics of a medical device.

The first strategic question is to define precisely what the business actually does and how. It is not only the marketing description that matters, but the real scientific and medical substance of the activity as assessed by supervisory authorities.

If you offer a comprehensive programme including medical consultations and interpretation of tests, your activities will likely fall under the Czech Act on Health Services. This entails strict requirements for authorisation to provide healthcare services, staff qualifications and record-keeping.

This segment typically features combined models where food supplements, cosmetics, diagnostic devices and mobile applications operate within one ecosystem. From a legal perspective, you must assess the exact regulatory regime for each component separately.

Each of these categories is subject to strict and different rules for placing on the market, mandatory information, supervision and advertising. Without coordinated legal advice, it is easy in practice to create a model that is illegal in some part.

From the perspective of the ARROWS legal team, it is therefore crucial to create a complete regulatory map of the entire project for the client at the outset. This will precisely describe the individual products and services and assign the relevant legal regimes to them.

Early analysis saves months of delay when scaling and minimises the risk of an immediate shutdown by the authorities. If you are planning expansion or an investor entry, specialists from ARROWS (office@arws.cz) will prepare this map for you.

Healthcare services, longevity clinics and the boundary with wellness

As soon as a project involves the provision of healthcare services, such as preventive screenings, infusion therapy or anti-ageing procedures, it is subject to the Czech Act on Health Services. The provider must obtain authorisation from the regional authority.

To obtain authorisation, it is necessary to meet strict staffing requirements, have the operating rules approved by the public health authority, and ensure appropriate material and technical equipment. Meeting all of these statutory conditions is absolutely essential for the lawful operation of a clinic.

In the longevity clinic sector, the myth still appears that regulation is substantially looser for self-paying clients. However, the legal regime for providing healthcare services is entirely independent of the method of financing care.

Any changes in operations, such as introducing new methods or relocating, must be reported to the administrative authority. Providing care contrary to the granted authorisation is an administrative offence with a fine of up to CZK 1,000,000.

A frequent stumbling block in the longevity business is also the formal set-up of cooperation with external physicians. It is necessary to clearly determine whether the physician acts as an independent provider or whether they act in the name of, and under the responsibility of, your clinic.

Properly setting up contracts and informed consents is key to eliminating risks associated with harm to health. The attorneys at ARROWS, a Prague-based law firm, regularly review these contractual chains in practice and set up safe relationships.

If a longevity clinic combines medical procedures with wellness, these service streams must be strictly separated. Attempts to present invasive methods as regenerative wellness procedures end in severe sanctions by the authorities.

Wellness, anti-ageing and the risk of a hidden healthcare service

The wellness, biohacking and anti-ageing programme sector is attractive due to its flexibility and the absence of complex licensing. However, the legal boundary between wellness and a healthcare service is defined under Czech law by the purpose and methods of the activity.

If the interpretation of blood tests is carried out by a person without the relevant healthcare education, this constitutes the provision of a hidden healthcare service. Using medical terminology in the marketing of wellness services creates a strong suspicion of circumventing the law.

From the perspective of civil liability for personal injury, a risk in wellness services is the absence of proper documentation and informed consents. If a client suffers a complication, courts assess the situation according to strict standards.

If the operator cannot prove that the client was properly informed of all risks and contraindications of the procedure, they bear liability for the harm. This may have fatal financial and reputational consequences for the operator.

For all hybrid wellness and biohacking projects, it is necessary to create a robust system of client documentation. It is also important to clearly state that the services provided do not in any way replace medical care.

If the project targets multiple countries, it is necessary to take into account that the definition of a healthcare service differs across EU Member States. Legal experts from ARROWS (office@arws.cz) will help you set up an international model safely.

Medicinal products, food supplements and cosmetics in the anti-ageing segment

In the longevity segment, the primary products are those intended for internal use or topical application, ranging from dietary supplements to cosmetics. From a legal perspective, there is a strict prohibition on confusing or substituting the individual categories of these products.

SÚKL (the Czech State Institute for Drug Control) has the authority to decide whether a product presented as a dietary supplement is in fact an unregistered medicinal product. Such a decision results in an immediate sales ban, withdrawal from the market, and a high fine.

For dietary supplements, there is an absolute ban on making so-called medicinal claims. The product must not state that it prevents or treats any human disease, and only approved health claims may be used.

Attempts to circumvent this rule by referring to independent studies or through influencer statements are heavily fined. At ARROWS, a Prague-based law firm, we help clients set up marketing and product texts safely, without the risk of sanctions.

Clinical trials, experimental treatment and frontier longevity innovations

The most progressive projects in the longevity field work with experimental methods such as autologous cell therapies, stem cell applications, or gene therapy. Carrying out these activities is subject to the strictest possible regulation.

If these methods are presented as research, they must meet the requirements of the Clinical Trials Regulation. Conducting an unauthorised clinical trial is a serious administrative offence with direct criminal liability.

In the case of off-label prescribing, the physician bears full responsibility for any negative consequences to the patient’s health. Prescribing an approved medicine for a different indication is only possible if strict statutory conditions are met.

Using these medicines for preventive purposes without proper justification represents a huge risk for clinics. At ARROWS, a Prague-based law firm, we help innovative clinics design a lawful structure for the development and application of these methods.

Digital health, data and artificial intelligence in the longevity business

Digital health platforms and telemedicine applications form the backbone of the modern longevity business. In the Czech legal environment, there has been a major shift with the introduction of a legislative framework for the provision of healthcare services remotely.

The operator of a telemedicine platform must meet strict conditions regarding authorisation, technical standards, and record-keeping. Communication channels must guarantee absolute security of data transmission and reliable identification of both parties.

When providing telemedicine cross-border within the European Union, specific rules must be respected. If the platform actively targets patients in another state, it must also meet the local requirements of the relevant regulators.

Software as a medical device, wearables and data ecosystems

One of the most common mistakes made by technology companies in the longevity segment is underestimating the correct classification of their software. Mobile applications and web platforms evaluating biomarkers may be considered a medical device.

If the software is intended for the diagnosis, prevention, or monitoring of diseases, it is subject to the strict MDR Regulation. Placing such software on the market without the required CE certification constitutes a serious breach of the law with high fines.

If your application only displays data from fitness bands without clinical analyses, it may remain in the wellness regime. However, once it starts recommending dosage or diagnosing risks, it becomes a medical device.

This boundary is very narrow and requires expert assessment before the application is launched. The attorneys of ARROWS, a Prague-based law firm, carry out comprehensive analyses for developers and help set application functions in compliance with regulations.

Protection of personal and genetic data and medical documentation

Data is the most valuable, but also the riskiest, asset across the entire longevity sector. Health information and genetic data obtained from DNA tests fall under special categories of personal data under the GDPR.

For commercial longevity projects, the primary legal basis is the data subject’s explicit consent. This consent must meet exceptionally strict standards and must be granted separately from the terms and conditions.

If you plan to use the data for secondary purposes such as scientific research or algorithm training, you must meet the requirements of the EHDS. These regulations introduce strict rules for the secure anonymisation of health data.

When integrating medical documentation, access may be granted only to authorised healthcare personnel bound by confidentiality. A leak or unauthorised disclosure of this sensitive data to third parties may lead to crippling fines from the ÚOOÚ (the Czech Data Protection Authority).

Artificial intelligence in diagnostics and personalised medicine

The deployment of artificial intelligence to predict biological age or generate recommendations is subject to the European AI Act. AI systems used in healthcare are often classified as high-risk.

Operators of these systems must meet demanding obligations, including risk management, data governance, and human oversight. If an AI system does not meet the requirements of the regulation, the operator faces astronomical fines.

ARROWS, a Prague-based law firm, has a specialised team for IT and IP law. Our specialists will help you implement the requirements of the AI Act directly into your project’s development processes.

Business models, contracts and liability in the longevity and health business

The relationship between a longevity provider and a client is legally hybrid and combines elements of a healthcare services agreement with consumer contracts. The foundation of a safe legal architecture is high-quality terms and conditions.

The general terms and conditions must clearly define the scope of services, payment terms, and the exclusion of liability for medical decisions in wellness programmes. This is how you prevent future disputes with dissatisfied clients.

Extraordinary attention must be paid to informed consents, which must not be drafted as a general waiver of rights. They must constitute a detailed and demonstrable briefing of the client on the specifics, risks, and realistic expectations of the programme.

If a client undergoes innovative therapy, the informed consent must explicitly include information that this is a method with non-guaranteed results. This step significantly reduces the risk of successful claims for damages.

B2B contracts with technology suppliers, laboratories and partners

The operation of a longevity clinic or platform depends on external partners. Each such relationship must be covered by a robust B2B contract that reflects the specific regulatory risks of the healthcare and technology sectors.

Contracts with laboratories must precisely define liability for the accuracy of test results, the handling of biological samples, and penalties for breaches of agreed standards. It must be contractually resolved who is responsible for any incorrect interpretation of data.

For cloud solutions and telemedicine platforms, it is essential to agree on a high system availability percentage. An outage of a system storing medical records may result in endangering patients’ health.

Contracts with IT suppliers who come into contact with health data must meet strict GDPR requirements. The attorneys of ARROWS advokátní kancelář have extensive experience negotiating these specific contracts.

Liability for personal injury and product liability

Liability for damage in the longevity business is divided into liability for professional misconduct and strict product liability for defective products. Each of these areas requires specific legal treatment.

If you sell products under your own brand, you become the manufacturer from a legal perspective. You then bear absolute liability for any personal injury caused by a defect in that product, regardless of fault.

When providing innovative services, the standard of professional care is assessed according to the current state of scientific knowledge. If a clinic applies an unverified method, it exposes itself to an increased risk of legal disputes.

The only defence is flawless documentation demonstrating that the procedure was chosen on the basis of relevant scientific studies with the patient’s full consent. A properly set insurance programme is also an essential condition for safe operation.

Standard commercial insurance policies often contain exclusions for experimental methods or cyber incidents. For maximum security for our clients, ARROWS advokátní kancelář is insured for damages up to CZK 400,000,000.

Advertising, health claims and unfair competition

Marketing in the longevity segment is under close scrutiny by regulators, and the Act on the Regulation of Advertising sets very strict rules. These relate in particular to advertising of medicinal products, food supplements and medical devices.

Advertising of food supplements must not suggest that the product has properties of prevention or treatment, or that it can replace a varied diet. Using unsubstantiated comparative claims against competitors may constitute unfair competition.

The ARROWS legal team carries out preventive audits of marketing campaigns and approves advertising claims before launch, saving clients the costs of fines.

Investments, M&A and structuring longevity and health projects

When an investor enters or when acquiring a longevity project, legal due diligence is significantly more complex than for ordinary technology startups. The investor does not focus only on finances, but primarily examines regulatory compliance.

The review focuses on the validity of licences, software classification, the setup of data protection consents, and contractual stability with key physicians. Any shortcomings in these areas may lead to the immediate termination of investment negotiations.

If due diligence reveals systemic deficiencies, it may lead to a drastic reduction in the valuation of the entire project. For founders, it is therefore crucial to have all legal and regulatory aspects resolved even before approaching investors.

Regulated changes to ownership structure and approval processes

In the regulated healthcare sector, changes to the ownership structure cannot be made entirely freely. Although the transfer of ownership interests does not require approval by an authority, you must report any changes to statutory bodies or the professional representative within fifteen days.

Be aware that the authorisation to provide health services is non-transferable to another person. In the event of a transformation, the new entity must undergo a complete new licensing procedure from the very beginning.

The transaction must therefore be structured with regard to the time limits for the issuance of a new authorisation by the administrative authority. At ARROWS advokátní kancelář, we have extensive experience in transactional law and will safely guide you through the entire M&A process.

Intellectual property, know-how and data as key assets

In the longevity business, intellectual property is the most valuable part of the company’s overall value. This includes patented food supplement formulations, source codes of diagnostic applications, artificial intelligence algorithms, and unique know-how.

As part of investment transactions, it is necessary to demonstrate that all rights are fully and lawfully owned by the target company. A common mistake is software development by external programmers without a proper written agreement on the transfer of rights.

For databases of genetic and health data, it is strictly examined whether the company has the right to commercially use them. If clients’ consents were drafted too narrowly, the new owner will not be able to use them legally.

This can, in effect, completely destroy the value of the entire built database for an investor. The attorneys of ARROWS advokátní kancelář help startups with comprehensive securing of rights and protection of intellectual property before an investor enters.

International elements and cross-border provision of services

Expanding the longevity business abroad brings the need to harmonise with the legal systems of the target countries. Although the principle of free movement of goods applies within the European Union, there are national specifics for healthcare products.

Each state has its own system for notification of food supplements and may apply stricter limits for certain substances. In addition, when transferring sensitive data cross-border outside the European Union, you must implement standard contractual clauses.

Thanks to our international network ARROWS International, we can coordinate legal advice in more than 90 jurisdictions and effectively support your global expansion.

Potential issues	How ARROWS can help (office@arws.cz)
Illegal provision of healthcare services: A clinic or platform provides care without a full licence, outside the scope of the granted authorisation, or without an appointed professional representative.	We will carry out a legal audit, set up the correct authorisation structure and prepare applications to the relevant Regional Authorities and represent you throughout the entire licensing process to minimise operational downtime and fines.
Incorrect product classification: A food supplement, cosmetic product or software shows characteristics of a medicinal product or a medical device, creating a risk of action by SÚKL/SZPI.	We will assess the correct regulatory status of the product, propose adjustments to the composition, texts and claims, prepare documentation for notification, and represent you in proceedings before supervisory authorities.
Leakage or misuse of health and genetic data: A cyber incident in the IT system, unauthorised employee access to sensitive data, or invalid GDPR consents.	We will set up full GDPR compliance for sensitive data, prepare DPA agreements, train staff, and in the event of an incident ensure crisis management, communication with the Czech Data Protection Authority (ÚOOÚ), and minimisation of the risk of class actions.
Dispute with a client over personal injury: Health complications after an invasive procedure, a complaint about the ineffectiveness of an expensive longevity programme, or a dispute over the validity of informed consent.	We will analyse client documentation, propose an out-of-court settlement strategy and, if necessary, represent you before Czech courts. We will coordinate communication with the insurer and arrange expert opinions.
Investment transaction blocked due to regulatory risks: During due diligence, an investor identifies serious legal defects and conditions the capital entry on costly remedial measures.	We will conduct a fast and effective internal audit of your project, identify weak points, propose remedies before approaching investors, and prepare watertight transaction documentation.

Final summary

Longevity and the health business is an exceptionally attractive and dynamic sector with enormous growth potential, but it is also one of the most heavily regulated business environments. Success in this area requires a deep understanding of the legal context.

Successful scaling and investment protection require viewing law as a strategic framework for stable growth. Correct classification of products and services at the very beginning of the project and consistent protection of sensitive data are the fundamental pillars on which every serious project must be built.

ARROWS advokátní kancelář has a specialised team of lawyers with experience in medical law, IT/IP regulation and M&A transactions. To ensure maximum security for our clients, we are insured for professional liability with a limit of CZK 400,000,000.

Do not improvise where your clients’ health and the value of your business are at stake. For a non-binding consultation or a detailed legal audit of your longevity project, you can contact ARROWS advokátní kancelář at any time by email at office@arws.cz.

FAQ

1. Do we need a lawyer already at the stage when we only have an idea and the first prototype of a longevity service, or is it enough to involve one only before an investor comes in?
Involving legal counsel already at the concept and prototype stage is a critical success factor. Early analysis helps you steer product development in the right direction, avoid the pitfalls of unregistered medical devices, and save enormous costs of rebuilding the entire system in the future. A prepared compliance model also dramatically increases the chance of attracting high-quality investors. If you want to validate your concept from a legal perspective, you can contact ARROWS advokátní kancelář via office@arws.cz.

2. How do we know whether we are still in a wellness mode, or whether we are already providing a healthcare service and must have a licence?
The line is determined by the purpose, methods and the way you present your activity. If you perform diagnostics (for example blood sampling and analysis, genetic analyses), propose therapeutic procedures, or recommend changes to medication with the aim of treating or preventing diseases, you are providing a healthcare service. If you only recommend general changes in diet, exercise or mental hygiene without a link to specific pathologies, it is wellness. For an accurate assessment, your model needs to be reviewed with the help of the legal team at ARROWS advokátní kancelář (office@arws.cz).

3. Can our clients’ health and genetic data be used for research and business development, or do legal regulations make that impossible?
Using such data is legally possible, but it requires strict compliance with the GDPR and the new EHDS framework. Clients must provide explicit, informed and voluntary consent for this secondary use of data, and it must not be hidden in terms and conditions. Data should be pseudonymised or anonymised to the maximum extent possible. ARROWS advokátní kancelář will help you design an end-to-end data strategy in compliance with the law (office@arws.cz).

4. What is the difference between a standard technology startup and a longevity & health startup from the perspective of legal risks?
A longevity and health startup operates in a highly regulated environment where compliance failure does not only mean data loss, but a direct threat to human health and life. This entails stricter supervision by public authorities, the need to obtain specific licences, strict limits on advertising and marketing, and the need to implement rules for high-risk AI systems. If you want to be prepared for investor scrutiny, it is advisable to work with lawyers from ARROWS advokátní kancelář (office@arws.cz).

5. What should we do if a regulator has already contacted us with questions or has initiated an inspection of our longevity business?
Stay calm and contact a legal representative specialising in healthcare and administrative law without delay. Do not provide the supervisory authority with any ill-considered statements or written materials without prior legal consultation. The first response often determines the outcome of the entire administrative proceedings and the amount of any potential fine. ARROWS advokátní kancelář regularly represents clients during inspections and will help you minimise the impact of the entire situation (office@arws.cz).

6. Can a longevity & health project be set up to be compatible with future regulatory changes, especially in AI and data?
Yes—the key is a flexible and modular legal and technological architecture of the project (compliance by design). This means developing software with security standards in mind, keeping clearly separated databases for different purposes, and regularly updating contractual relationships in response to legislative developments. Monitoring legislative trends allows you to stay one step ahead of the competition. The lawyers at ARROWS advokátní kancelář monitor regulatory developments and will design the project to be resilient to change (office@arws.cz).

Disclaimer: The information contained in this article is for general informational purposes only and serves as a basic guide to the issue as of 2026. Although we strive for maximum accuracy, laws and their interpretation evolve over time. We are ARROWS Law Firm, a member of the Czech Bar Association (our supervisory authority), and for the maximum security of our clients, we are insured for professional liability with a limit of CZK 400,000,000. To verify the current wording of the regulations and their application to your specific situation, it is necessary to contact ARROWS Law Firm directly (office@arws.cz). We are not liable for any damages arising from the independent use of the information in this article without prior individual legal consultation.

Read also: